The Impact of the Covid-19 Pandemic on New and Ongoing Clinical Trials
Navigating the COVID-19 Pandemic, Preparing for the Rest of 2020 & Planning a Return to "Normalcy" in the New Clinical Trial Landscape

June 25 - 26, 2020 | Virtual Event

View Program

Vendor Registration

Free End User Registration

Diane Maloney

Associate Director Policy, Center for Biologics Evaluation and Research (CBER) Food and Drug Administration (FDA)

Check out the incredible speaker line-up to see who will be joining Diane.

QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com